List view / Grid view
FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option…
FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for moderate-to-severe opioid use disorder...
The FDA has approved Ogivri as a biosimilar to Herceptin…
The FDA has approved Ogivri as a biosimilar to Herceptin for the treatment of patients with breast or metastatic stomach cancer whose tumours overexpress the HER2 gene...
The FDA has approved Yescarta, a cell-based gene therapy, to…
The FDA has approved Yescarta, a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma...
Mvasi, a biosimilar to the cancer drug Avastin, is approved…
Mvasi, a biosimilar to the cancer drug Avastin, is approved for certain colorectal, lung, brain, kidney and cervical cancers…
